Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.
Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M; MR-Linac Consortium Clinical Steering Committee. Kerkmeijer LG, et al. Among authors: verheij m. Front Oncol. 2016 Oct 13;6:215. doi: 10.3389/fonc.2016.00215. eCollection 2016. Front Oncol. 2016. PMID: 27790408 Free PMC article.
Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR, McLaughlin M, Kyula JN, Neijenhuis S, Khan A, Good J, Zaidi S, Powell NG, Meier P, Collins I, Garrett MD, Verheij M, Harrington KJ. Borst GR, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1110-8. doi: 10.1016/j.ijrobp.2012.08.006. Epub 2012 Sep 14. Int J Radiat Oncol Biol Phys. 2013. PMID: 22981708
The transformation of radiation oncology using real-time magnetic resonance guidance: A review.
Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ; MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium. Hall WA, et al. Among authors: verheij m. Eur J Cancer. 2019 Nov;122:42-52. doi: 10.1016/j.ejca.2019.07.021. Epub 2019 Oct 12. Eur J Cancer. 2019. PMID: 31614288 Free PMC article. Review.
Towards Personalization in the Curative Treatment of Gastric Cancer.
Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Slagter AE, et al. Among authors: verheij m. Front Oncol. 2020 Nov 30;10:614907. doi: 10.3389/fonc.2020.614907. eCollection 2020. Front Oncol. 2020. PMID: 33330111 Free PMC article. Review.
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Eijkelboom AH, de Munck L, Vrancken Peeters MTFD, Broeders MJM, Strobbe LJA, Bos MEMM, Schmidt MK, Guerrero Paez C, Smidt ML, Bessems M, Verloop J, Linn S, Lobbes MBI, Honkoop AH, van den Bongard DHJG, Westenend PJ, Wesseling J, Menke-van der Houven van Oordt CW, Tjan-Heijnen VCG, Siesling S; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Eijkelboom AH, et al. J Hematol Oncol. 2021 Apr 17;14(1):64. doi: 10.1186/s13045-021-01073-7. J Hematol Oncol. 2021. PMID: 33865430 Free PMC article.
Adverse event development in clinical oncology trials.
Walraven I, Aaronson N, Sonke JJ, Verheij M, Belderbos J. Walraven I, et al. Among authors: verheij m. Lancet Oncol. 2016 Jul;17(7):e263. doi: 10.1016/S1470-2045(16)30197-8. Lancet Oncol. 2016. PMID: 27396639 No abstract available.
318 results